1. Home
  2. TLS vs STRO Comparison

TLS vs STRO Comparison

Compare TLS & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$5.16

Market Cap

463.8M

Sector

Technology

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$10.75

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLS
STRO
Founded
1969
2003
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
463.8M
85.0M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
TLS
STRO
Price
$5.16
$10.75
Analyst Decision
Buy
Hold
Analyst Count
5
8
Target Price
$7.75
$18.29
AVG Volume (30 Days)
1.0M
122.9K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$144,400,000.00
$105,646,000.00
Revenue This Year
$52.27
$63.08
Revenue Next Year
$20.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.44
N/A
52 Week Low
$1.83
$5.23
52 Week High
$8.36
$21.50

Technical Indicators

Market Signals
Indicator
TLS
STRO
Relative Strength Index (RSI) 38.84 81.15
Support Level $5.05 $8.49
Resistance Level $5.85 $11.09
Average True Range (ATR) 0.34 0.83
MACD -0.02 0.03
Stochastic Oscillator 13.30 89.41

Price Performance

Historical Comparison
TLS
STRO

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: